Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Retatrutide is an investigational triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from approved agents like semaglutide and tirzepatide, though it has not yet received regulatory approval
In Ireland, both medications are usually available only with a private prescription and are not currently covered under the Drug Payment Scheme (DPS) when prescribed for weight management
Symptoms of food poisoning can include upset stomach, vomiting, diarrhea, and fever
Pain, severe symptoms, bleeding, fecal seepage, rectal protrusion, bowel habit changes, and a family history of colon cancer all merit immediate physician evaluation
US$ 25.48
US$ 25.93
US$ 21.99
US$ 20.11
US$ 27.26
US$ 29.89
